C. C. Roberts, A. S. Tadesse, J. Sands, T. Halvorsen, T. L. Schofield et al., Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays, Journal of Clinical Virology, vol.36, issue.4, pp.277-282, 2006.
DOI : 10.1016/j.jcv.2006.03.013

M. Amrani, K. Lalaoui, M. Mzibri, P. Lazo, and M. A. Belabbas, Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs), Journal of Clinical Virology, vol.27, issue.3, pp.286-295, 2003.
DOI : 10.1016/S1386-6532(02)00227-5

M. H. Schiffman and P. Castle, Epidemiologic Studies of a Necessary Causal Risk Factor: Human Papillomavirus Infection and Cervical Neoplasia, JNCI Journal of the National Cancer Institute, vol.95, issue.6, p.2, 2003.
DOI : 10.1093/jnci/95.6.E2

Z. Hausen and H. , Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis, Journal of the National Cancer Institute, vol.92, issue.9, pp.690-698, 2000.
DOI : 10.1093/jnci/92.9.690
URL : http://jnci.oxfordjournals.org/cgi/content/short/92/9/690

A. Ferenczy and E. Franco, Cervical-cancer screening beyond the year 2000, The Lancet Oncology, vol.2, issue.1, pp.27-32, 2001.
DOI : 10.1016/S1470-2045(00)00192-3

P. Holowaty, A. B. Miller, T. Rohan, and T. To, Natural History of Dysplasia of the Uterine Cervix, JNCI Journal of the National Cancer Institute, vol.91, issue.3, pp.252-258, 1999.
DOI : 10.1093/jnci/91.3.252

K. J. Syrjanen, Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV), European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.65, issue.1, pp.45-53, 1996.
DOI : 10.1016/0028-2243(95)02303-A

P. A. Jones and S. B. Baylin, The fundamental role of epigenetic events in cancer, Nat. Rev. Genet, vol.3, pp.415-428, 2002.

A. P. Feinberg and B. Tycko, The history of cancer epigenetics, Nature Reviews Cancer, vol.74, issue.2, pp.143-153, 2004.
DOI : 10.1038/nrc1279

A. P. Bird, CpG-rich islands and the function of DNA methylation, Nature, vol.26, issue.6067, pp.209-213, 1986.
DOI : 10.1038/321209a0

F. Larsen, G. Gundersen, R. Lopez, and H. Prydz, CpG islands as gene markers in the human genome, Genomics, vol.13, issue.4, pp.1095-1107, 1992.
DOI : 10.1016/0888-7543(92)90024-M

A. G. Knudson, Two genetic hits (more or less) to cancer, Nature Reviews Cancer, vol.1, issue.2, pp.157-162, 2001.
DOI : 10.1038/35101031

S. E. Cottrell and P. W. Laird, Sensitive Detection of DNA Methylation, Annals of the New York Academy of Sciences, vol.30, issue.3, pp.120-130, 2003.
DOI : 10.1111/j.1749-6632.2003.tb05967.x

P. W. Laird, Early detection: The power and the promise of DNA methylation markers, Nature Reviews Cancer, vol.3, issue.4, pp.253-266, 2003.
DOI : 10.1038/nrc1045

Y. C. Tsai, F. A. Gonzales, H. D. Nguyen, T. T. Nguyen, and P. A. Jones, The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines, Cancer Res, vol.58, pp.1245-1252, 1998.

X. Liu, A. Clements, and K. Zhao, Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor, Journal of Biological Chemistry, vol.281, issue.1, pp.578-586, 2006.
DOI : 10.1074/jbc.M508455200

T. A. Ivanova, D. A. Golovina, L. E. Zavalishina, G. M. Volgareva, A. N. Katargin et al., Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4ain HPV-positive cervical carcinomas, BMC Cancer, vol.118, issue.1, pp.47-56, 2007.
DOI : 10.1002/ijc.21466

K. Nehls, S. Vinokurova, D. Schmidt, F. Kommoss, M. Reuschenbach et al., p16 methylation does not affect protein expression in cervical carcinogenesis, European Journal of Cancer, vol.44, issue.16, pp.2496-2505, 2008.
DOI : 10.1016/j.ejca.2008.07.014

N. Wentzensen, C. Bergeron, F. Cas, S. Vinokurova, and M. Doeberitz, Triage of women with ASCUS and LSIL cytology, Cancer, vol.188, issue.1, pp.58-66, 2007.
DOI : 10.1002/cncr.22420

B. E. Gould-rothberg and M. B. Bracken, E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis, Breast Cancer Research and Treatment, vol.329, issue.2, pp.139-148, 2006.
DOI : 10.1007/s10549-006-9248-2

S. Hirohashi, Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers, The American Journal of Pathology, vol.153, issue.2, pp.333-339, 1998.
DOI : 10.1016/S0002-9440(10)65575-7

C. J. De-boer, E. Van-dorst, H. Van-krieken, C. M. Jansen-van-rhijn, S. O. Warnaar et al., Changing Roles of Cadherins and Catenins during Progression of Squamous Intraepithelial Lesions in the Uterine Cervix, The American Journal of Pathology, vol.155, issue.2, pp.505-515, 1999.
DOI : 10.1016/S0002-9440(10)65146-2

C. L. Chen, S. S. Liu, S. M. Ipb, L. C. Wongb, T. Y. Ng et al., E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours, European Journal of Cancer, vol.39, issue.4, pp.517-523, 2003.
DOI : 10.1016/S0959-8049(02)00175-2

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular cloning: A laboratory manual. Cold Spring Harbor, 1989.

J. G. Herman, J. R. Graff, S. Myohanen, B. D. Nelkin, S. B. Baylin et al., PCR: A novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. USA 93, pp.9821-9826, 1996.

M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman, A gene hypermethylation profile of human cancer, Cancer Res, vol.61, pp.3225-3229, 2001.

S. M. Dong, H. S. Kim, S. H. Rha, and D. Sidransky, Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix, Clin. Cancer Res, vol.7, pp.1982-1986, 2001.

I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge et al., Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection, Cancer Res, vol.63, pp.1888-1893, 2003.

H. M. Müller, A. Widschwendter, H. Fiegl, G. Goebel, A. Wiedemair et al., A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer, Cancer Letters, vol.209, issue.2, pp.231-236, 2004.
DOI : 10.1016/j.canlet.2003.12.016

A. Virmani, C. Muller, A. Rayhi, S. Zoechbauer-mueller, M. Mathis et al., Aberrant methylation during cervical carcinogenesis, Clin. Cancer Res, vol.7, pp.584-589, 2001.

A. Widschwendter, C. Gattringer, L. Ivarsson, H. Fiegl, A. Schneitter et al., Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors, Clinical Cancer Research, vol.10, issue.10, pp.3396-3400, 2004.
DOI : 10.1158/1078-0432.CCR-03-0143

A. Widschwendter, L. Ivarsson, A. Blassnig, H. M. Müller, H. Fiegl et al., CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients, International Journal of Cancer, vol.340, issue.2, pp.163-166, 2004.
DOI : 10.1002/ijc.11706

A. Widschwendter, H. M. Müller, H. Fiegl, L. Ivarsson, A. Wiedemair et al., DNA Methylation in Serum and Tumors of Cervical Cancer Patients, Clinical Cancer Research, vol.10, issue.2, pp.565-571, 2004.
DOI : 10.1158/1078-0432.CCR-0825-03

H. J. Yang, V. Liu, Y. Wang, P. Tsang, and H. Ngan, Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data, BMC Cancer, vol.9, issue.1, pp.212-221, 2006.
DOI : 10.1038/sj.onc.1205195

S. W. Lowe, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, vol.88, pp.593-602, 1997.

B. L. Ziober, S. S. Silverman, and R. H. Kramer, Adhesive Mechanisms Regulating Invasion and Metastasis in Oral Cancer, Critical Reviews in Oral Biology & Medicine, vol.12, issue.6, pp.499-510, 2001.
DOI : 10.1177/10454411010120060401

A. J. Karayiannakis, K. N. Syrigos, E. Chatzigianni, S. Papanikolaou, D. Alexiou et al., Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer, Anticancer Res, vol.18, pp.4177-4180, 1998.

M. A. Sulzer, M. P. Leers, J. A. Van-noord, E. C. Bollen, and P. H. Theunissen, Reduced E-Cadherin Expression Is Associated with Increased Lymph Node Metastasis and Unfavorable Prognosis in Non-small Cell Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.4, pp.1319-1323, 1998.
DOI : 10.1164/ajrccm.157.4.9703099

Z. Zheng, J. Pan, B. Chu, Y. C. Wong, A. L. Cheung et al., Downregulation and abnormal expression of E-cadherin and ??-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis, Human Pathology, vol.30, issue.4, pp.458-466, 1999.
DOI : 10.1016/S0046-8177(99)90123-5

G. Narayan, H. Arias-pulido, S. Koul, H. Vargas, F. F. Zhang et al., Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome, Molecular Cancer, vol.2, issue.1, pp.24-35, 2003.
DOI : 10.1186/1476-4598-2-24

E. Carico, M. Atlante, and B. Bucci, E-Cadherin and ??-Catenin Expression during Tumor Progression of Cervical Carcinoma, Gynecologic Oncology, vol.80, issue.2, pp.156-161, 2001.
DOI : 10.1006/gyno.2000.6035

J. R. Graff, E. Gabrielson, and H. Fujii, Methylation Patterns of the E-cadherin 5' CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression, Journal of Biological Chemistry, vol.275, issue.4, pp.2727-2732, 2000.
DOI : 10.1074/jbc.275.4.2727

H. J. Yang, V. W. Liu, Y. Wang, K. Y. Chan, and P. C. Tsang, Detection of hypermethylated genes in tumor and plasma of cervical cancer patients, Gynecologic Oncology, vol.93, issue.2, pp.435-440, 2004.
DOI : 10.1016/j.ygyno.2004.01.039

N. Shivapurkar, M. E. Sherman, V. Stastny, C. Echebiri, J. S. Rader et al., Evaluation of candidate methylation markers to detect cervical neoplasia, Gynecologic Oncology, vol.107, issue.3, pp.549-553, 2007.
DOI : 10.1016/j.ygyno.2007.08.057

S. Kang, J. Kim, H. Kim, J. Shim, E. Nam et al., Methylation of p16INK4a Is a Non-Rare Event in Cervical Intraepithelial Neoplasia, Diagnostic Molecular Pathology, vol.15, issue.2, pp.74-82, 2006.
DOI : 10.1097/00019606-200606000-00003

Y. Oki, E. Aoki, and J. P. Issa, Decitabine???Bedside to bench, Critical Reviews in Oncology/Hematology, vol.61, issue.2, pp.140-152, 2007.
DOI : 10.1016/j.critrevonc.2006.07.010

S. Charfi, T. Boudawara, A. Ghorbel, J. Daoud, M. Frikha et al., Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients, Anticancer Res, vol.28, pp.2161-2167, 2008.

D. M. Bornman, S. Mathew, J. Alsruhe, J. G. Herman, and E. Gabrielson, Methylation of the E-cadherin Gene in Bladder Neoplasia and in Normal Urothelial Epithelium from Elderly Individuals, The American Journal of Pathology, vol.159, issue.3, pp.831-835, 2001.
DOI : 10.1016/S0002-9440(10)61758-0

R. Kamiyama, K. Hirokawa, and Y. Yuasa, Age-related hypermethylation of the hMLH1 promoter in gastric cancers, Int. J. Cancer, vol.94, pp.208-211, 2001.

T. Waki, G. Tamura, T. Tsuchiya, K. Sato, S. Nishizuka et al., Promoter Methylation Status of E-Cadherin, hMLH1, and p16 Genes in Nonneoplastic Gastric Epithelia, The American Journal of Pathology, vol.161, issue.2, pp.399-403, 2002.
DOI : 10.1016/S0002-9440(10)64195-8